Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ghrelin Levels in Pancreatic Cancer Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT00225745
First received: September 22, 2005
Last updated: October 12, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)